Stay updated on Safety of AK001 in Clinical Trial
Sign up to get notified when there's something new on the Safety of AK001 in Clinical Trial page.

Latest updates to the Safety of AK001 in Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a Locations section with California as a location and updates to revision v3.3.3. The older California Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer displays the government funding status notice that previously appeared; all study details, trial status, and eligibility criteria remain as before. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedVisual and formatting updates to the Study Details page. Core study data such as eligibility criteria, outcomes, and dates appear unchanged.SummaryDifference0.5%

- Check83 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference6%

- Check90 days agoChange DetectedAdded a new version label (v3.1.0) and removed several drug-safety topics (MedlinePlus Drug Safety, Substandard Drugs, Counterfeit Drugs, and the older version label v3.0.2), resulting in a narrower core content area focused on the updated version.SummaryDifference1%

Stay in the know with updates to Safety of AK001 in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of AK001 in Clinical Trial page.